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 Historically, damage to human tissues and organs has been treated with the use of 
prostheses or transplants. Materials used for transplants are categorized as follows: 
autograft (derived from the same individual); allograft (derived from a different 
individual of the same species); xenograft (derived from non-human sources) or alloplast 
(derived from synthetic material).
1
 
 As material science has evolved, better and more durable synthetic materials (e.g., 
Teflon and silicone) have been used to replace or rebuild diseased tissues or parts of the 
human body.  While these newer materials offer some superior characteristics compared 
with older materials, their physical and mechanical properties are still quite distinct from 
the original human form, and they supply more of a structural rather than a functional 
replacement of the original tissue.
2
  
 As the study of cell biology has progressed, the field of tissue engineering has 
evolved.
3
  Tissue engineering is the field of functional restoration of tissue structure and 
physiology for impaired or damaged tissues because of cancer, disease, or trauma.
4
 The 
field exploits living cells in various ways to maintain, enhance, or restore tissues and 
organs,
5
 and in the process it utilizes and integrates principles from various other fields 
such as cell transplantation, material science, and engineering.
2
    
 An outgrowth of the increased knowledge in the field of tissue engineering has 
been the development of a scientific discipline termed “regenerative medicine.”3  
Regenerative therapy involves the combined interplay of three key elements: stem cells, 
some type of scaffold, and cytokines.
2
 Regenerative therapies have become an alternate 
3 
 
method for restoration of tissues and organs instead of autografts, allografts or artificial 
prostheses.
6
  
 Tissue engineering and regenerative therapies have shown promising results in the 
field of dentistry. Tissue engineering approaches can aid in either the replacement of 
damaged tooth structures or in the repair/regeneration of the pulp-dentin complex 
(regenerative endodontics).
2
         
 Regenerative endodontic procedures are currently performed to treat infected 
immature teeth utilizing the “revascularization method.”7 This method includes two 
steps: disinfection of the root canal followed by the laceration of apical tissues to induce 
blood flow into the root canal space (RCS). The blood clot formed in the canal serves as a 
fibrin scaffold for the accumulation of stem cells and other cells with dentin/root 
formation capability.
8
 This protocol has resulted in continued root formation (in length 
and width) 
9
 in certain clinical cases. However, the adequacy of hemorrhage induced in 
the apical tissues has a significant impact on the quality of the regenerated dental 
structures. 
10
 This phenomenon indicates that the blood clot itself may play an important 
role in continued root formation by locally releasing molecular signals, which induce 
angiogenesis. Successful angiogenesis is then crucial for the vitality of the newly 
regenerated pulp tissues and for the initiation of continued root development. Therefore, 
the production of angiogenic cytokines from the local surviving cells or the effective 
delivery of exogenous angiogenic cytokines to the desired area is one of the key 
components in regenerative endodontic treatment.        
 It is believed that an appropriate exogenous scaffold could aid the endogenous 
elements (fibrin meshwork and molecular signals in blood clot) and result in more 
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predictable regenerative endodontic procedures.
11
  Platelet-rich plasma (PRP) has been 
reported recently as a scaffold material whose usage has met with mixed results.
12-14
 
Investigators continue to search for materials that can serve as better scaffolds.
15
  To 
accomplish the structural and functional replacement of the target tissue, the ideal 
scaffold must facilitate the growth of the requisite cell population (by such processes as 
attachment, migration, proliferation, and three-dimensional spatial organization). The two 
categories of materials that are most commonly used in tissue engineering are synthetic 
polymers such as poly(lactic) acid (PLA) and poly(glycolic) acid (PGA), and natural 
matrices derived from biological sources such as reconstituted collagen.
16
  Extracellular 
matrix (ECM) membranes belong to the second category and are indeed biological 
membranes that are used in regenerative procedures. ECM membranes used in clinical or 
research studies are usually derived from porcine organs such as the urinary bladder or 
small intestine. After “decellularization and terminal sterilization,”17  the ECM becomes a 
membrane that possesses structural and functional proteins (collagens types I, III, IV, and 
VI, glycosaminoglycans, glycoproteins and proteoglycans)
18 
in their native three-
dimensional organization, but devoid of species-specific cellular components that would 
trigger an immune response in the host.  The preservation of the natural three-
dimensional organization of the molecules in the membrane distinguishes ECM scaffolds 
from synthetic scaffolds and might contribute to “constructive tissue remodeling instead 
of scar tissue.”17           
 
DynaMatrix® is a biological ECM scaffold product that is marketed to dental 
practitioners. In addition to the structural and functional proteins mentioned above, 
DynaMatrix contains biological signals such as cytokines.
17
  In dentistry, DynaMatrix has 
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been used for periodontal restorative procedures and for alveolar ridge preservation.
19
 Its 
track record of successful use in periodontal procedures encourages investigation of the 
material for use in regenerative endodontic procedures. Specifically, DynaMatrix may be 
placed within the root canal system of the immature tooth to facilitate the continued 
development of the entire length of the root from the apical foramen to the level of the 
dentin enamel junction (DEJ).  As a scaffold containing biological signals, DynaMatrix 
has the potential to induce angiogenesis and encourage the migration of cells that are 
involved in the continued development of the root canal system.  This continued 
development of the root length and width would be particularly valuable in the cervical 
area of the tooth, which is prone to fracture when underdeveloped and is an area to which 
cells involved in continued root formation may have difficulty migrating without the aid 
of a scaffold.          
 The aim of this current study was to determine if the exposure of human dental 
pulp stem cells (HDPSC) to the DynaMatrix membrane will result in an increased 
production of angiogenic cytokines that are critical for pulp/root regeneration.  
Angiogenesis cytokine arrays have been established as a viable method for assessing 
expression of cytokines.
20
  HDPSC were chosen as they are expected to be found in the 
apical papilla and the infected immature root canal system of teeth that current 
regenerative endodontic techniques are designed to treat. 
21
      
  
 
 
6 
 
CLINICAL SIGNIFICANCE         
 If the experimental group reveals significantly different expression levels of the 
angiogenesis cytokines that would be conducive to pulp regeneration or root formation, 
further experimentation might establish the DynaMatrix membrane as a potentially 
beneficial scaffold for use in regenerative endodontic procedures.   
                                                                         
HYPOTHESES                                                                                                                
Null Hypothesis          
 No statistically significant differences in the expression of angiogenic cytokines 
will be demonstrated between the experimental group and the control groups.   
Alternative Hypothesis         
 Statistically significant differences in the expression of angiogenic cytokines will 
be demonstrated between the experimental group (HDPSC seeded on DynaMatrix) when 
compared with the control groups (untreated cells or the DynaMatrix membrane alone 
without cells). 
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HISTORY OF ENDODONTICS 
 In 1687 Charles Allen published a book credited with being the first book in 
English devoted exclusively to dentistry.
22
  This volume contained a description of 
“taking out the rotten teeth or stumps and putting in their places some sound ones drawn 
immediately out of some poor body’s head.”23      
 In 1728 Pierre Fauchard wrote The Surgeon Dentist, which provided accurate 
descriptions of root canals and pulp cavities of various teeth. The book also described the 
practice of relieving abscesses and draining pus by creating access holes in teeth which 
were left open for two to three months. Later, the pulp chamber was filled with lead 
foil.
22
  In addition to drainage procedures, Fauchard described a pulp extirpation 
procedure using a small pin and a treatment for deep carious lesions, which involved 
application of the oil of cloves or cinnamon to the affected area for several weeks.
22
 
 The German dentist Phillip Pfaff (whose patient pool included Frederick the 
Great) mentioned a pulp-capping procedure in 1756, which involved cutting out a piece 
of gold or lead to fit approximately the shape of the opening over the pulp. The metal was 
shaped so as to be concave to avoid direct contact with the pulp.
22
   
 Louis XV’s dentist, Bourdet, described in 1757 a process of extracting carious 
teeth, filling the root canals with gold or lead, and then replanting them. He also 
described an “intentional” endodontic treatment involving dislocation of a symptomatic 
tooth in order to sever the nerve, followed by immediate replacement of the tooth into its 
socket.
23
  Bourdet was not the first to treat symptomatic teeth in this manner; the same 
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procedure had been described as early as the 11
th
 century AD by the Arabian physician 
Avicenna.
24
           
 Robert Woofendale, an English practitioner who came to New York in 1766, is 
credited with performing the first endodontic procedures in the US.  He sought to 
alleviate dental pain by cauterizing the pulp with a hot instrument, followed by placement 
of cotton pellets into the canals.
25,26
  The German dentist Frederick Hirsch wrote toward 
the end of the 18
th
 century about diagnosing dental disease by tapping the suspected teeth, 
and noted that diseased teeth were tender to percussion. He recommended perforation of 
the tooth in the cervical area followed by insertion of a red-hot probe. The final step in 
his protocol was to fill the cavity with lead.
27 
 By the early 19
th
 century, ideas were beginning to emerge concerning the 
importance of tooth vitality and how this concept related to pulp treatment. This time 
period has been dubbed “The Vitalistic Era” by some.22  In 1805 J.B. Gariot became one 
of the first to advance the idea that obliteration of the pulp does not destroy the vitality of 
the tooth.
28
  Building on this idea, an Irish clinician by the name of Edward Hudson, who 
practiced in Philadelphia, is typically given credit for being the first to place fillings in 
root canals in 1809. He designed his own instruments, which he used to pack gold foil in 
the canals.
25,29
  Hudson was innovative for his time in that he advocated the preservation 
of natural dentition.
30
         
 John Callow in his work Opinions on the Causes and Effects of Diseases in the 
Teeth and Gums (1819) credits Charles Bew with describing the flow of blood into the 
pulp through the apical foramen and out through the dentinal wall and the periodontal 
membrane. Thus, Bew joined others of his time who subscribed to the “vitalistic theory” 
10 
 
of teeth.
28
  One of Bew’s contemporaries, a German immigrant named Leonard Koecker, 
wrote Principles of Dental Surgery in 1826. This book became a standard in the field for 
50 years.
30
 Koecker believed that destruction of the pulp would cause the whole dentinal 
core of the tooth to immediately die, thereby rendering the tooth a foreign body requiring 
extraction. To avoid this fate for the tooth, Koecker popularized the pulp capping 
procedure (essentially the same procedure described by Pfaff in 1756).
28,31,32
    
 In his book System of Dental Surgery published in 1829, SS Fitch formulated and 
presented the principles of the “vitalistic” or “double membrane” theory.22  He advocated 
the notion that teeth were like hollow bones with an outer periosteum (periodontal 
membrane) and an inner periosteum that lay between the pulp and the dentin. With this 
model in mind, Fitch believed that the crown was nourished exclusively by the dental 
pulp or its membrane, whereas the roots were supplied by the pulp membrane on the 
interior and by the alveolar membrane on the exterior.
22
 This concept led to the practice 
of removing the crown of teeth after extirpation of the pulp (since its source of 
sustenance had been removed), while the root was left in the socket (because it was 
believed to receive continued nourishment via the periodontal membrane). The root was 
then restored with a pivot crown.
28,32
       
 An opposing philosophical camp advocated a “nonvitalistic”22 concept. The 
esteemed British surgeon and anatomist John Hunter believed that dentin possessed none 
of the properties of living tissue and was devoid of circulation, sensibility and capability 
of repair. Hunter was joined by Cuvier and Robertson from England, who were also 
proponents of the nonvitalistic theory.
28
       
 A significant change in the way vital pulp extirpations were performed occurred 
11 
 
in 1836 when Shearjashub Spooner of New York used a protoplasmic poison (arsenic 
trioxide) to devitalize the pulp before removing it.
25
  Though novel for modern Western 
medicine, this approach was actually not original but actually dates back to ancient 
Chinese medicine when it was described as a treatment for jaw abscesses.
24
  This 
treatment immediately became popular due to its success at practically eliminating the 
pain involved in the removal of vital pulps. Unfortunately, this also led to imprudent use 
of arsenic for devitalization of pulps and for treatment of teeth with dentin 
hypersensitivity. Arsenic was still being used by many dentists as recently as the 1920s to 
destroy the pulp before removing it.
33
      
 In 1837 Jacob and Joseph Linderer (father and son) advocated using essential or 
narcotic oil as a pulpal obtundant prior to restoring a tooth with an exposed pulp.
34
 In 
1838 Edwin Maynard developed a root canal broach by filing a watch spring, and also 
designed hoe-like instruments for shaping and enlarging root canals.
35
 In 1839, Baker 
described a treatment for an exposed nerve that included removal of the nerve, followed 
by cleaning the canal and filling the canal with gold foil. He is commonly credited with 
writing the first published account of pulpal extirpation, canal cleaning, and root canal 
filling.
22,24
           
 Throughout the 1850s, plugs of wood soaked in creosote were used as root canal 
filling material.
22
 Liquid cement was used in conjunction with the wooden plug to create 
a seal. This early sealer contained gutta-percha, quick-lime, powdered glass, feldspar, and 
metal filings.  This concoction was also used as a temporary restoration material.
33
 
 In 1857, Thomas Rogers gave a presentation on pulp capping at a meeting of the 
Odontological Society of London.  He reported on a series of 220 pulp capping cases, 
12 
 
202 of which were considered successful. Rogers described the conditions that would 
lead to the success of the procedure, including: general good health of the patient, 
freedom from inflammatory tendencies, absence of previous considerable pain from the 
affected tooth, absence of disease in other parts of the tooth, and no use of caustics to 
decrease the pain. Rogers’ overall assessment and treatment recommendations could hold 
up under modern scrutiny, except for the final recommendation in his protocol in the case 
of pulp-capping failure: the application of three leeches and a laxative.
22
  
 Later innovations in the 19
th
 century brought endodontic treatment ever closer to 
modern techniques. In 1864 S.C. Barnum of New York introduced the use of the rubber 
dam to isolate the tooth during the placement of gold foil restorations. It was quickly 
adopted for use in endodontic procedures to provide a more aseptic environment for 
treatment.
24,25
  G.A. Bowman of Missouri is generally given credit for being the first to 
use only gutta-percha for filling root canals in 1867.
25,29,36
     
 Also in 1867 (the first year Joseph Lister described using carbolic acid as an 
antiseptic for surgical procedures), the German team of Leber and Rottenstein  proved the 
existence of a parasite they called Leptothrix buccalis, which they found to exist on tooth 
surfaces, carious lesions, and within dentinal tubules. This information led to a better 
understanding that tooth decay could cause gangrene (necrosis) of the pulp, and soon 
attempts were being made to apply Lister’s principles of antiseptic treatment to the realm 
of pulp treatment.
22,34
  In this same year, Magitot suggested using an electric current for 
pulp testing.
31
          
 By the late 1870s, the theory of vitalism was beginning to give way to the septic 
theory, which asserted that pathogenic organisms were the most common cause of 
13 
 
diseases of the pulp.  This theory was advocated by G.O. Rogers in 1878 and Charles S. 
Tomes in 1879.
28
 In 1882 Arthur Underwood further developed the septic theory by 
suggesting that if pathogens could be successfully excluded from the pulp space through 
the use of powerful antiseptic agents, suppuration of the pulp and resultant alveolar 
abscesses could be prevented.
22
  This idea provided new justification for pulp therapy 
procedures that included caustic germicides for bacterial elimination, a practice that 
remained common for more than 30 years.
28
      
 In 1895, Dr. Bowman of Missouri introduced a solution of chloroform and gutta-
percha, which was appropriately named chloropercha.  It was used with gutta-percha 
cones for obturation of root canals.  This technique quickly gained wide acceptance, and 
one of its chief advocates was M.L. Rhein of New York, who further developed and 
described the technique several years later.
25
       
 Thomas Alva Edison, one of America’s greatest inventors, discovered in 1898 
that calcium tungstate could be used to fabricate fluorescent dental mirrors that could be 
used to observe pathologic conditions and endodontic results. However, the device 
exposed clinicians and patients to excessive amounts of radiation, an appreciation of 
which finally led to the declined usage of the mirrors in the 1930s.
30
     
 In 1905, Einhorn developed procaine (Novocaine), which provided an alternative 
to the previously used cocaine (which had been used as an anesthetic agent for 20 years, 
but only sparingly due to its high toxicity).  Though it represented a promising 
breakthrough in dental pain control, the wide usage of procaine for mucosal injections 
was stifled initially by an inefficient protocol that required dissolving the tablet in 
solution, followed by boiling, cooling, and aspiration into a syringe.  It would take 
14 
 
another 25 years for more user-friendly block anesthesia techniques to be perfected.
33,35,37
 
 Dr. Meyer L. Rhein, a physician-dentist from New York, developed a technique 
in 1908 for determining canal length and degree of obturation that utilized a diagnostic 
wire in conjunction with radiographs.
25,31
  G.V. Black also suggested measurement 
control to determine the length of the canal and the size of the apical foramen to avoid 
overfilling.
22
 In the second decade of the 20
th
 century, ideas began percolating in the 
medical and dental community that would eventually be synthesized into what is now 
referred to as the “Focal Theory of Infection” (or Theory of Focal Infection) that 
postulates a myriad of diseases caused by microorganisms (bacteria, fungi, viruses) that 
arise endogenously from a focus of infection.”38  Though this concept was not truly new 
(Hippocrates has been credited with perhaps the first “report” of focal infection by 
attributing the cure of a case of arthritis to a tooth extraction),
39
  it experienced a 
resurgence due in part to E.C. Rosenow, a protégé of Frank Billings, (a name commonly 
affiliated with the popularization of this theory)
38
 who did work in 1909 showing that 
streptococci were present in many diseased organs, and that these bacteria were capable 
of traveling in the bloodstream to establish a separate infection at a distant site.
37
  
 Another major event that propelled the Theory of  Focal Infection to a state of 
widespread acceptance
22
 occurred in October of 1910, when British physician and 
pathologist William Hunter lectured on the topic at McGill University in Montreal. The 
presentation, entitled “The Role of Sepsis and Antisepsis in Medicine” was published in 
1911 in the Lancet, a respected medical journal of the time.
22
    
 The widespread popularity of the Theory of Focal Infection led to increased 
scrutiny on endodontic procedures.  Many physicians and dentists began to recommend 
15 
 
extraction of all endodontically treated teeth (the 100 percenters).  Others recommended 
removal of all non-vital teeth and yet others suggested that all teeth, whether diseased or 
not, be removed for the sake of prevention, as well as treatment (“therapeutic 
edentulation” or “the clean-sweep”).38,40 
 The philosophy of the 100 percenters became the most popular approach to dental 
practice and this persisted up until approximately 1930 when the pendulum began to 
swing back toward more conservative approaches.
22
  This change in popular sentiment 
included a refocusing on such things as definitive diagnosis, aseptic techniques, 
bacteriological culturing, and improved radiographic practices in conjunction with root 
canal therapy.
41
  These ideas were not widely adopted immediately, however, and it 
would take approximately a decade before this more conservative approach to the 
treatment of dental disease would take hold generally.
22
    
 In the year 1937, multiple advances ushered in a period referred to by some as 
“the scientific era.”22  In that year, work by Logan showed that bacteria can be present in 
normal tissues without having a pathological effect,
26
 and Tunnicliff and Hammond 
found that microorganisms could be found in the pulps of extracted teeth “without any 
evidence of inflammatory tissue changes.”22,37  Also in 1937, Cecil of Cornell Medical 
College reported 200 cases in which arthritis had been treated by the removal of 
suspected foci with little evidence of  positive effects. This information prompted Burket 
to conclude that any improvement following the removal of bacterial foci was more 
likely the result of an associative relationship”22 between the foci and the disease rather 
than a causative one.
42
  The work of these and other men effectively sounded the death 
knell for the formerly widespread practice of wholesale extraction of distressed or non-
16 
 
vital teeth.
22
           
 In the early 1940s, Fred Adams and Louis Grossman advanced the idea of 
utilizing antibiotics as an adjunct to root canal therapy. Adams reported using 
sulfanilamide in treating periapical infections and is credited as the first to use penicillin 
in pulp canal therapy.
22,37
  Grossman advocated use of a non-aqueous formulation of 
penicillin for use in endodontics citing stability of the compound decreased cost as 
advantages over the conventional form. Dr. Grossman would later use penicillin-laced 
paper points to disinfect root canals.
29
        
 The year 1943 marked the dawn of organized endodontics.  In that year, the 
American Association of Endodontists (AAE) was formed in Chicago, Illinois.
43
  By 
1949, this group was investigating the possibility of establishing a specialty board in 
endodontics, and by 1956, this idea became a reality with the formation of the American 
Board of Endodontics.
44
  Finally, due to remarkable development and growth of 
endodontics during the previous 25 years and the tireless efforts of AAE leaders,
43
 the 
American Dental Association recognized endodontics as a specialty in 1963. The first 
examination and certification of Diplomates occurred 2 years later in 1965.
22,43
  The 
American Association of Endodontists currently boasts approximately 7000 members and 
approximately one-fourth of those are board certified.
45
   
  
THEORY OF ENDODONTICS 
 One of the foundational studies of modern endodontics was conducted in 1965.  It 
showed that the pulps of germ-free rats, when exposed and left open to food impaction, 
survived despite the trauma.
46
  This highlighted the important role microbes play in 
endodontic infections, and the supreme importance of reducing bacterial loads in order to 
17 
 
achieve success following endodontic therapy.
47-49
  Failure to achieve this goal can result 
in apical or periradicular periodontitis, which is defined as inflammation and destruction 
of the periodontium that may or may not produce symptoms.
50
     
 A 1955 study by Stewart highlighted three phases of endodontic treatment:   
chemomechanical preparation, microbial control, and obturation of the root canal.
51
  Of 
these three phases, Stewart identified chemomechanical preparation as the most 
important phase.  This was later confirmed by Grossman,
52
 who also identified 13 
principles of effective root canal therapy as follows:  
1. Aseptic technique 
2. Instruments should remain within the root canal.  
3. Instruments should never be forced apically. 
4. Canal space must be enlarged from its original size. 
5. Root canal system should be continuously irrigated with an antiseptic.   
6. Solutions should remain within the canal space. 
 
7. Fistulas do not require special treatment. 
 
8. A negative culture should be obtained before obturation of the root canal. 
 
9. A hermetic seal of the root canal system should be obtained. 
 
10. Obturation material should not be irrigating to the periapical tissues. 
 
11. If an acute alveolar abscess is present, proper drainage must be established. 
 
12. Injections into infectious areas should be avoided. 
 
13. Apical surgery may be required to promote healing of the pulpless tooth. 
 Schilder discussed the importance of chemomechanical preparation of the canal 
with instruments and antiseptics followed by a three-dimensional obturation to the 
18 
 
cementodentinal junction or 0.5 mm to 1 mm from the radiographic apex.
53
  These 
principles were later reiterated by Ford,
54
 who cited three reasons that it is important to 
achieve a three-dimensional obturation.  First, it leaves less space for bacterial 
colonization; second, it prevents apical contamination; and third, it prevents movement of 
bacteria along the walls of the canal. Ford also stressed the importance of aseptic 
technique including the use of rubber dams, adequate coronal restoration of root canal 
treated teeth and appropriate recall to monitor healing.                         
 
IRRIGATION            
 The utilization of irrigation solutions is an important part of non-surgical root 
canal therapy. It aids in the elimination of bacteria, bacterial by-products and debris from 
the root canal system. Irrigation solutions can often reach portions of the canal space that 
are not reached by mechanical debridement alone. Studies have shown that up to 53 
percent of canal walls remain untouched following instrumentation.
55,56
  Specific 
desirable properties of irrigation solutions were identified by Harrison
57
 as follows: 
antimicrobial efficacy, tissue dissolution capacity, biocompatibility, and ability to 
adjunctively debride the root canal system. Various irrigation solution have been studied 
and utilized clinically. 
 
Sodium Hypochlorite         
 Sodium Hypochlorite (NaOCl) is a powerful antimicrobial agent and is effective 
at dissolution of collagen and other components of organic tissue. It gained popularity as 
an antimicrobial agent during World War I and was later applied in endodontic 
treatment.
58
  NaOCl has shown superior capacity for microbe elimination within the root 
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canal system when compared to sterile saline.
59
  It is available in various concentrations 
ranging from 0.5 to 6.0 percent.
60
  The concentration of the solution can affect both its 
tissue dissolving and antibacterial properties. At lower concentrations, NaOCl is 
primarily effective at dissolving necrotic tissues.
61
 At higher concentrations, its tissue 
dissolving and antimicrobial properties are both enhanced.
62
  Its tissue-dissolving 
efficacy can also be enhanced by increased duration of exposure, as well as increased 
temperature.
63,64
  For every 5°-C rise in temperature, the bactericidal rates for NaOCl 
doubled.
65
  Due to its favorable characteristics, NaOCl is used widely and often 
considered the single most effective endodontic irrigation solution.
66,67
      
 
Chlorhexidine           
 Chlorhexidine (CHX) is a broad spectrum antimicrobial agent that is effective 
against yeast as well as gram-negative and gram-positive bacteria. It is available in 
various concentrations from 0.12 to 2 percent.
58
  Its effectiveness against bacteria results 
from its overall positive electrostatic charge, allowing it to bind to negatively charged 
bacterial cell walls. This results in damage to the cell by increasing permeability of the 
cell wall, which diminishes the bacteria’s ability to regulate its internal environment.68,69  
At low concentrations, CHX has a bacteriostatic effect primarily by interfering with cell 
metabolism, while at higher concentrations it acts as a detergent and is bactericidal.
58
  In 
endodontics, CHX is useful due to its substantivity (extended microbial effect) which 
results from its ability to bind to hydroxyapatite.
58
  This allows it to remain on dentinal 
walls for extended periods of time, thereby reducing bacterial colonization.
70
  The 
antimicrobial activity of CHX is directly related to its concentration, and accordingly, 
2.0- percent preparations have been shown to be more effective endodontic irrigation 
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solutions than 0.12-percent solutions.
71
  Due to its favorable properties, CHX has been 
advocated as the final solution in an endodontic irrigation regimen, especially in the case 
of endodontic retreatment.
72
           
 Unlike NaOCl, CHX does not possess tissue dissolving properties, which 
practically necessitates that it be used in conjunction with other irrigation solutions in 
order to maximize chemomechanical debridement of the root canal system.
58
  This 
presents a potential problem in that CHX has been shown to form a potentially 
carcinogenic precipitate when mixed with NaOCl.  Originally identified as para-
chloroaniline (PCA) by Basrani,
73
 subsequent investigation suggested that the precipitate 
formed upon mixing CHX and NaOCl is actually parachlorophenylurea (PCU) and 
parachlorophenylguanidyl-1,6-diguanidyl-hexane (PCGH).
74
  
 
EDTA           
 Endodontic instrumentation results in the formation of what has been termed a 
“smear layer.”  The smear layer consists of organic and inorganic substances such as 
fragments of odontoblastic processes and necrotic debris,
75
 as well as fragments of 
hydroxyapatite.  There is controversy surrounding the question of whether removal of the 
smear layer is advisable.
75
  A relatively recently conducted systematic review and meta-
analysis on the effects of the smear layer removal and its effect on sealability of the root 
canal system concluded that smear layer removal improves the fluid-tight seal of the 
obturation.
76
  This finding would seem to advocate an irrigation regimen that includes 
irrigation solutions capable of removing the smear layer.  
 Ethylenediamene Tetra-Acetic Acid (EDTA) has been used as an endodontic 
irrigation solution. It has shown efficacy at chelation and removal of inorganic 
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components of the smear layer. The concentration of EDTA most commonly used in 
endodontics is 17 percent, which has been shown to remove the smear layer in one 
minute.
58
  EDTA’s effects are self-limiting, and its effectiveness can be decreased in the 
presence of organic debris.
77
  However, when used in conjunction with NaOCl, a 
synergistic effect resulting in the removal of the entire smear layer and deeper penetration 
of irrigation solutions into dentinal tubules has been observed.
78,79
   
 
OBTURATION            
 Chemomechanical debridement and final irrigation set the stage for the obturation 
phase of non-surgical root canal treatment. The objective of obturation is to prevent 
infection of the periapical tissues by sealing the root canal space.
80
 Various materials 
have been utilized and advocated for use in obturation. Most techniques use a core 
material and a sealer to achieve a tight seal; the most commonly used core material is 
gutta-percha.
58
  In a 1946 publication,
81
 Dr. Louis Grossman identified multiple qualities 
that would characterize an ideal obturation material. They are that the material should be: 
1) easily introduced; 2) liquid or semisolid which later solidifies; 3) capable of sealing the 
canal laterally and apically; 4) free of shrinkage; 5) resistant to moisture; 6) 
bacteriostatic; 7) devoid of a tendency to stain tooth structures; 8) biocompatible with 
periapical tissues; 9) easily removed; 10) sterile when introduced into the canal; and 11) 
radiopaque.             
 The quality of the obturation is related to the success of endodontic treatment.  
One aspect of obturation quality is the length of the fill.  A recent meta-analysis 
investigated this issue and found that success rates are improved when the obturation 
material does not extend beyond the apex.
82
  Peng
83
 found that obturation techniques that 
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utilize warm gutta-percha resulted in a higher rate of overextension of obturation 
material, so extra care is required when using this type of technique.  The highest success 
rates are achieved when adequate chemomechanical debridement and obturation are 
followed up by a high quality coronal restoration.
84
       
 However, some clinical situations present particular challenges to the 
achievement of these goals.  For example, immature necrotic teeth with thin dentinal 
walls pose a risk of fracture open condensation of obturation materials, and the 
blunderbuss apical architecture make it very difficult to achieve an apical seal with 
traditional materials.
85
  For this particular clinical situation, alternative treatment 
methodologies are required.  These methodologies are typically referred to collectively as 
“regenerative endodontics.”  
 
REGENERATIVE ENDODONTICS      
 Regenerative endodontic procedures can be defined as “biologically based 
procedures designed to replace damaged structures, including dentin and root structures, 
as well as cells of the pulp-dentin complex.”86 Though the concept of regenerative 
endodontic procedures is not new (Dr. B.W. Hermann reported on the use of Ca(OH)2 in 
a case report involving a vital pulp amputation in 1952
87
 and B.N. Ostby explored the 
role of the blood clot in endodontics in a paper published in 1961
88
 ), it has received 
increasing attention in recent years.
89,90
  The typical clinical scenario in which 
regenerative endodontic procedures have been employed has been in cases of immature 
infected teeth with incompletely developed apices.
21,86,90
  However, some investigators 
have described the potential to apply these principles to a wide array of clinical situations 
including mature teeth with closed apices and eventually to such endeavors as 
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“replacement of periapical tissues, periodontal ligaments, gingiva, and even whole 
teeth.”86 
 Some have questioned the value of applying the principles of regenerative 
medicine to endodontics.
86
  It has been stated that the pulp plays no significant role in the 
fully developed tooth in terms of form, functions or esthetics and therefore replacing it 
with a synthetic material as in conventional root canal treatment is the most practical 
approach.  Murray and colleagues refute these points
86
 citing the possibility for staining 
of tooth structure by endodontic filling materials and sealers.
91,92
  They also point out the 
potential for decreased fracture resistance of root dentin caused by long term Ca(OH)2 
exposure
93
 that is a part of certain treatment protocols for infected immature teeth.  
Others have proposed applying the principles of regenerative procedures to treat root 
perforations.
89
          
 Though minor variations exist in the precise protocols used in the regenerative 
endodontic procedures that have been reported in the literature, most practitioners have 
followed an approach that begins with disinfection via irrigation of the canal space.
90
  
Irrigation protocols for immature teeth with open apices differ from those for teeth with 
closed apices.  For regenerative procedures, a reduced concentration of 2.5 percent 
NaOCl is recommended to avoid cytotoxicity to apical tissues including stem cells.
94
  
Additionally, the use of CHX in regeneration procedures has been discouraged due to its 
detrimental effects on stem cells of the apical papilla (SCAP).
94
  Conversely, EDTA has 
been shown to promote SCAP survival. One suggested mechanism for this effect is that 
irrigation with EDTA promotes the release of dentinal growth factors that were 
embedded in the dentin during dentinogenesis.
15,86
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 Irrigation is followed by placement of an intracanal medicament. Bacteria present 
in necrotic root canals and deep within the tubules of radicular dentin have been found to 
be predominantly obligate anaerobes.
95
 Metronidazole has a wide spectrum of 
bactericidal action against oral obligate anaerobes, even within the necrotic pulp.
96,97
  
One study found that 99 percent of bacteria in infected root dentin were killed in the 
presence of metronidazole.
96
 Another study found that a mixture of ciprofloxacin, 
metronidazole, and minocycline can sterilize root dentin.
97
  These findings have led to the 
widespread use of triple antibiotic paste (TAP) in regenerative endodontic procedures. In 
addition to its effectiveness at eradicating pathogenic bacteria, this mixture has been 
shown to be well tolerated by apical tissues.
98
  One downside of TAP, however, is that 
the minocycline component can cause dentinal staining.
99
  Calcium hydroxide is another 
intracanal medicament option for regenerative endodontic procedures.  It has been shown 
to reduce bacterial levels,
100
 but it can also result in the initiation of apical hard tissue 
barrier formation by sterile necrosis of the apical tissues.
101
  This process tends to hinder 
endodontic regeneration. Following placement of the intracanal medicament, the tooth 
undergoing regenerative treatment is sealed with a temporary restoration and the patient 
is recalled in three to four weeks.           
 At the following appointment, bleeding is induced into the canal from the apical 
tissues, and a permanent coronal seal is placed.
90,85  
The induction of bleeding into the 
canal space is performed in order to provide a fibrin scaffold that can be populated by the 
cells involved in regeneration, as well as to provide a source of cytokines that aid in 
regeneration and repair.
85,86,90
  The scaffold provides a biological “three dimensional 
microenvironment for cell growth and differentiation, promoting cell adhesion, and 
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migration.”102           
 While little data are available concerning success rates of regenerative procedures 
(the majority of the literature consists of case reports with failures not being reported), a 
recent study did reveal that regenerative techniques were “associated with significantly 
greater increases in root length and thickness in comparison with calcium hydroxide 
apexification and MTA apexification as well as excellent overall survival rates.”103   
 
ANGIOGENESIS          
 A key component to achieving success in regenerative endodontic procedures 
involves establishing an adequate blood supply to the tissues involved.
11,86,90
  The 
establishment of such a blood supply requires the growth of existing vessels to form new 
branches and extensions in the periapical area and into the root canal itself.
85
  This 
process of new blood vessel growth from previously existing blood vessels is termed 
“angiogenesis.”104  Other physiologic processes that involve angiogenesis include wound 
repair, the ovarian/menstrual cycle, and embryogenesis.
105
   
 Angiogenesis can be classified into two types: sprouting angiogenesis and 
intussusceptive (or splitting) angiogenesis.
104
  Sprouting angiogenesis has been the most 
extensively studied method of vessel formation in humans, and it involves a complex 
series of interactions between various growth factors and cytokines that govern the 
development of the new vasculature.
106
  Some of these chemical messengers induce 
angiogenesis (angiogenic), while others play an inhibitory role (angiostatic).  The balance 
between the angiogenic and angiostatic factors is crucial, as aberrant angiogenesis can 
lead to “chronic inflammation associated with chronic fibroproliferative disorders as well 
as growth and metastasis of solid tumors.”105         
26 
 
CYTOKINES  
 Cytokines are defined as “secreted proteins that regulate important cellular 
responses such as proliferation and differentiation.”107  Various cytokines that play 
integral roles in the process of angiogenesis have been identified.  One of the earliest 
steps in the process of angiogenesis involves an increase in the permeability of blood 
vessels in response to the presence of vascular endothelial growth factor (VEGF).  This 
leads to extravasation of plasma proteins which create a temporary scaffold for migrating 
endothelial cells,
106
 which are induced to migrate in part by the action of insulin like 
growth factor - 1 (IGF-1).
108
  Angiogenin and monocyte chemotactic protein - 1 (MCP-1) 
are growth factors that aid the process by increasing new vessel growth.
109-111
  Interleukin 
6 and interleukin 8 (IL-6, IL-8) have also been shown to play a role in angiogenesis, 
sometimes promoting and sometimes inhibiting angiogenesis depending upon the 
interplay between multiple chemical messengers in the local microenvironment.
112-115
  
 Transforming growth factor-beta (TGF-β) is another angiogenesis promoting 
cytokine.
116
  In addition to other tissues, it is found in the dentin matrix. It is anti-
inflammatory, promotes wound healing and has been used to promote mineralization of 
pulp tissue.
86,117
 Fibroblast growth factor (FGF) is secreted from a wide range of cells and 
promotes proliferation of a variety of cell-types. It can be applied in regenerative 
endodontic procedures to increase stem cell numbers.
86,113
      
 One family of enzymes that plays a critical role in multiple physiologic processes 
is the matrix metalloproteinase (MMP) family. MMPs aid in development and 
morphogenesis of connective tissue and also function in the process of wound healing.  
However, when left unchecked, their activity has been implicated in multiple disease 
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processes including tumor cell metastasis, atherosclerosis, and arthritis.  Another family 
of molecules known as tissue inhibitors of metalloproteinases (TIMP) play an important 
role in regulating the activity of MMPs.
118
  There are four isotypes of TIMP,
119
 and types 
1-3 have been shown to have inhibitory effects on angiogenesis.
119-121
  Interferon gamma 
(IFN-γ) has also been shown to inhibit angiogenesis in vitro.  It achieves this inhibitory 
effect, at least in part, by opposing the action of platelet derived growth factor (PDGF).
122
  
PDGF-BB has been shown to modulate endothelial proliferation and angiogenesis.
123
  
Another intracellular mediator, epithelial neutrophil-activating protein - 78 (ENA-78), 
plays an important role (as its name suggests) in acute inflammation by binding to 
receptors on polymorphonuclear leukocytes (PMNs, neutrophils) to “mediate their 
spatially-localized activation.”124  However, studies have also demonstrated a strong 
correlation between higher ENA-78 levels and increased vascularity of certain 
tissues.
105,125
    
 
ADULT STEM CELLS         
 All tissues are generated from stem cell precursors.
126
  Stem cells can be defined 
as cells that have “the ability to continuously divide and produce progeny cells that 
differentiate (develop) into various other types of cells or tissues.”127  Stem cells are also 
commonly classified as either embryonic/fetal or adult/postnatal.
128
  One set of 
investigators expressed preference for the term postnatal over the term adult because 
cells that fall under this classification are present in babies, infants and children, and 
therefore, the term adult can be misleading. This same group advocated the use of the 
term embryonic rather than fetal, as most of the cells in this classification are indeed 
present in the embryonic stage rather than the fetal stage.
86
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 The importance of classifying stem cells in this manner (embryonic vs. postnatal) 
lies in the fact that the potential for stem cells to differentiate into different cell types 
(i.e., plasticity) differs between the two groups.
129
  Embryonic stem cells have historically 
shown greater plasticity than their postnatal counterparts.  However, more recent studies 
have demonstrated that postnatal stem cells have greater potential for plasticity than 
previously believed.
130
  Stem cells can also be described as totipotent, pluripotent, or 
multipotent.  Totipotent cells exhibit the greatest plasticity. They are found in a new 
embryo (1 day to 3 days) and have the potential to differentiate into an entire individual.  
Pluripotent cells are also highly plastic and can differentiate into over 200 different cell 
types. These cells are present in the blastocyst stage (approximately 5 days to 14 days).  
Multipotent cells are more differentiated than the previous two types, but can still be 
induced to form other tissues. Sources of multipotent stem cells include fetal tissue, cord 
blood and postnatal stem cells such as dental pulp stem cells.
86
   
 
HUMAN DENTAL STEM CELLS        
 One of the fundamental issues facing any attempt at tissue engineering is to 
determine the source of the cells that will be utilized.
85
  For regenerative endodontic 
procedures, the dental pulp and tissues of the periodontium serve as a reservoir of stem 
cells.
86
  Four different types of human dental stem cells have been identified and 
characterized
90:  dental pulp stem cells (DPSCs);131 stem cells from human exfoliated 
deciduous teeth (SHED);
132
 stem cells from apical papilla (SCAP);
133,134
 and periodontal 
ligament stem cells (PDLSCs).
135
  Of these four types, all but SHED are derived from 
permanent teeth.         
 Dental stem cells are a subclass of mesenchymal stem cells (MSCs) and they vary 
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in their ability to differentiate into specific tissue-forming cells. DPSCs can differentiate 
into odontoblast-like cells which can produce dentin-like tissue both in vivo and in 
vitro.
90
  They can also be induced under proper conditions to differentiate into cells 
capable of producing such disparate tissues as nerve, muscle, cartilage, bone and even 
adipose.
136-140
  The identification and isolation of these stem cells has led to a more 
complete understanding of the pulp and periodontal ligament tissues and their potential 
for regeneration even following tissue damage from trauma or infection. For example, the 
observation of severely infected immature teeth remaining capable of undergoing 
complete root maturation after proper disinfection procedures may be explained by the 
possibility that stem cells somehow evade death even in the noxious microenvironment of 
an infected tooth.
90,133,141
       
 According to one study, many adult tissues contain only 1 percent to 4 percent 
stem cells.
142
  Therefore, these cells need to be isolated and concentrated for later re-
introduction to the desired site of action or induced to migrate to the desired site via 
chemical messengers.  There are four methods commonly utilized to identify and isolate 
stem cells from mixed cell populations. These include: “(a) staining the cells with 
specific antibody markers and using a flow cytometer in a process called fluorescent 
antibody cell sorting (FACS); (b) immunomagnetic bead selection; (c) 
immunohistochemical staining; and (d) physiological and histological criteria, including 
phenotype (appearance), chemotaxis, proliferation, differentiation, and mineralizing 
activity.”86  Of the various types of dental stem cells, dental pulp stem cells are the most 
studied.
86
 These cells express specific surface proteins that can be utilized in the 
identification process.  Examples include alpha-smooth muscle actin, von Willebrand 
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factor CD146, and 3G5.
143
  Human pulp stem cells also have a fibroblast phenoptype, 
with specific proliferation, differentiation, and mineralizing activity patterns.
143,144
    
 
DYNAMATRIX          
 DynaMatrix is an extracellular matrix membrane derived from porcine small 
intestine submucosa (SIS).  It is marketed to dental practitioners for use in “guided bone 
and guided tissue regeneration procedures.”17  According to materials provided by the 
manufacturer (Cook Biotech, West Lafayette, IN), their SIS membranes are prepared by 
removing the tunica mucosa from the inner intestinal surface and the serosa and tunica 
muscularis from the outer intestinal surface.  Next, during processing with a series of 
surfactant and ionic solutions, the cells and nuclear matter are removed. This results in a 
three-dimensional, acellular, collagen-rich extracellular matrix (ECM) that is not 
chemically crosslinked.  The isolation and disinfection process preserves structural and 
functional bioactive molecules, including collagens (I, III, IV, VI) in their natural, three-
dimensional states. This provides the framework for the infiltration of host cells and 
lasting strength during the remodeling process; active cytokines such as fibroblast growth 
factor (FGF-2), connective tissue growth factor (CTGF), and transforming growth factor 
beta (TGF-β) all of which promote angiogenesis, participate in vascular repair and 
development, and stimulate migration and proliferation of cells; glycoproteins and other 
protein-carbohydrate complexes such as fibronectin, proteoglycans, and 
glycosaminoglycans.  These serve as chemo-attractors, provide cell attachment sites in 
the extracellular matrix, and help to regulate the complex processes of cell migration, 
proliferation, and differentiation.  Elastin is also present in negligible amounts.   
 With regards to its physical properties, the average pore size of the material is 17 
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μm, with a range from roughly 10 μm to 50 μm. Average thickness of SIS is 0.155 mm in 
the wet state.  Dry product as provided collapses to about 0.100 mm. The manufacturer 
further provides the following information concerning the safety of the product:   
All of our devices are composed of porcine small intestinal submucosa (SIS).  In 
order to ensure and maximize patient safety, Cook Biotech utilizes only healthy 
pigs raised at qualified and monitored producers and rendered at USDA-certified 
meat packing facilities.  All pigs are sourced in the United States.  Further, the 
packing facilities must process only pigs, minimizing the potential cross-
contamination with animal species known to have the potential for carrying 
transmissible spongiform encephalopathy (TSE).   However, there are no known 
naturally occurring TSEs in pigs and cross-species transmission is highly 
unlikely.
145
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MATERIALS AND METHODS 
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EXPERIMENTAL DESIGN 
 
 This study utilized human dental pulp stem cells (HDPSC) in vitro.   Three 
different groups were tested as follows: 1) control group 1- Human Dental Pulp Stem 
Cell (HDPSC) culture only; 2) control group 2 – DynaMatrix membranes placed in 
culture media without any cells present, and 3) experimental group- HDPSC seeded on 
DynaMatrix membranes. The conditioned media from the various groups were collected 
after 72 hours and tested for the expression of specific angiogenic cytokines that may 
play a role in regenerative endodontic treatment.        
 The HDPSC used in this study were purchased form Cook Biotech (Indianapolis, 
IN).  The protocol used by Cook Biotech to procure and treat the HDPSC has been 
outlined in the literature and is summarized below as published:
146
   
 
Tissue Processing and Cell Culture 
 
Collection and transport of extracted teeth 
 
Extracted human third molars were obtained with informed consent through a 
local oral/maxillofacial surgeon from patients aged 18 years to 30 years. Once extracted, 
teeth were placed into chilled solution vessels containing 20 mL of sterile phosphate 
buffered saline and transported to the lab for processing within 24 hours. 
 
Processing and tissue recovery 
Before digestion of dental tissue, teeth were disinfected by a protocol adopted and 
modified from cornea banking.
147
  The roots of cleaned teeth were separated from the 
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crown; the roots were split to reveal the dental pulp, which was then recovered with a 
curette for further processing or cryopreservation.         
 
Tissue digestion        
 Recovered dental tissue was placed into an enzyme bath consisting of a blend of 
saline with Type I and Type II Collagenase to liberate the cells. Once digestion was 
complete, the enzyme mixture was neutralized by addition of medium and the cells were 
plated as previously described.
148
  
 
Culture and expansion of fresh tissue digest 
For culture of fresh digested tissue, cells were plated immediately in a T-25 flask 
at a density of 1 tooth digest per flask and placed into a high humidity 37º C, 5.0-percent 
CO2 incubator.  No selection of stem cells was performed directly, and instead selective 
culture was used to maximize stem cell recovery. After 14 days of growth, adherent cells 
were dissociated from flasks and a cell count of total cells per flask was obtained via 
standard hemacytometer counting methods.       
 Cells were then sub-cultured for approximately 4 weeks, with medium changes 
taking place three times per week. Following trypsin dissociation, passage 3 cells were 
re-suspended in complete medium and were confirmed to meet minimal criteria to be 
called MSC by flow cytometry based on the International Society for Cell Therapy 
(ISCT) position paper. 
149
 Antibodies to human CD73, CD90, CD105, CD34, CD45, 
CD11b, CD19 and HLA-DR were obtained from BD Biosciences (San Jose, CA). 
Selected DPSC cultures were stained with the above antibodies and appropriate isotype 
controls per the manufacturer’s instructions and were analyzed using a FACSCalibur 
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instrument and CellQuest software (BD Biosciences).  Cells 95-percent positive for 
CD73, 90 and105, and 65-percent positive for CD34, 45, 11b, 19 and HLA-DR were 
confirmed DPSC.  The cells procured from Cook Biotech were subcultured.  HDPSC 
(50,000/well) were seeded on the plates (no membrane) or on DynaMatrix® membrane in 
the 6-well plates for 3 days. The conditioned media were collected and stored at -70º C 
before further analysis, and subsequently the concentrations of the total protein in the 
collected media were determined by the Bradford method using Bio-Rad protein assay. 
 
CYTOKINE ARRAY  
The release of multiple cytokines from the HDPSC or DynaMatrix alone, or from 
HDPSC seeded on DynaMatrix® membranes was evaluated utilizing RayBio Human 
Angiogenesis Antibody Array I (Table 1, RayBiotech Inc., Norcross, GA) according to 
the manufacturer’s protocol.20  In brief, the cytokine array membranes were blocked with 
1.0-percent serum for 30 minutes and then incubated for three hours with 200 ng of total 
protein from each of the samples, two hours with biotin-conjugated antibodies provided 
by the kit, and then two hours with horseradish peroxidase–conjugated streptavidin.   
Detection agents supplied in the kit were mixed and applied to each membrane for two 
minutes.  The cytokines on the membrane were then visualized by autoradiography on x-
ray film.  Each experiment was repeated three times. With two dots for each type of 
cytokine on each membrane, a total of four to six determinations for each cytokine 
(outliers removed) were used for further semi-quantification.    
 To determine the level of cytokine expression, the optical densities of the visible 
dots on the membrane were measured by Quantity One 1-D Analysis Software (Bio-Rad, 
Hercules, CA). The density of each dot was adjusted for the background using the 
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negative controls on each membrane and the different membranes were normalized by 
the positive controls on each membrane. The experiment was repeated three times and the 
averages were calculated. Group comparisons were performed using one-way ANOVA.  
Based on previous studies,
150-153
  this study had approximately 80-percent power to detect 
a fold-change of two, assuming two-sided tests each conducted at a 5.0-percent 
significance level and a within-group standard deviation equal to approximately one-half 
fold-change. 
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RESULTS 
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To determine the levels of cytokine expression, the optical densities of the visible 
dots on the membrane were measured by Quantity One 1-D Analysis Software (Bio-
Rad). For each membrane, the density of each dot was adjusted for the background by 
subtracting the average value of the negative controls on each membrane and then 
normalized by dividing by the average of the positive controls.  The experiment was run 
three times resulting in three membranes for each group.  This generated four to six 
densitometry readings (two per membrane, some statistical outliers removed) for each 
cytokine in each group.  Group comparisons were performed using one-way ANOVA. 
The cell-only group (C) had significantly lower ENA-78 (p = 0.0166), leptin (p = 
0.0208), PDGF-BB (p = 0.0034), VEGF (p = 0.0174), VEGF-D (p = 0.0230), and bFGF 
(p = 0.0047) compared to the DynaMatrix membrane-only group (M). C had significantly 
higher IL-6 (p = 0.0268), IL-8 (p = 0.0153), MCP-1 (p = 0.0021), TIMP-1 (p = 0.0027), 
and TIMP-2 (p = 0.0105) compared to M. 
C had significantly lower PDGF-BB (p = 0.0182) and bFGF (p = 0.0009) 
compared to the DynaMatrix membrane + dental pulp stem cell group (M+C). C had 
significantly higher IL-6 (p = 0.0203), IL-8 (p = 0.0097), MCP-1 (p = 0.0019), TIMP-1 
(p = 0.0006), and TIMP-2 (p = 0.0086) compared to M+C. C and M+C did not have 
significantly different ENA-78 (p = 0.78), leptin (p = 0.42), VEGF (p = 0.42), or VEGF-
D (p = 0.07). 
M had significantly lower bFGF (p = 0.0452) compared to M+C. M had 
significantly higher ENA-78 (p = 0.0178), TIMP-1 (p = 0.0363), and VEGF (p = 0.0117) 
39 
 
compared to M+C. M and M+C did not have significantly different IL-6 (p = 0.79), IL-8 
(p = 0.63), leptin (p = 0.06), MCP-1 (p = 0.92), PDGF-BB (p = 0.10), TIMP-2 (p = 0.81), 
or VEGF-D (p = 0.34). 
The groups did not have significantly different angiogenin (p = 0.20), EGF (p = 
0.27), GRO (p = 0.60), IFN-gamma (p = 1.00), IGF-I (p = 0.79), PIGF (p = 0.84), 
RANTES (p = 0.74), TGF-beta 1 (p = 0.70), or thrombopoietin (p = 0.22). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
40 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLES AND FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
41 
 
 
      
 
 
 
FIGURE 1. Experimental design overview. 
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FIGURE 2.  DynaMatrix membrane provided by manufacturer in large quantity. 
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FIGURE 3. Six-well plate showing three experimental groups with culture media 
in top three wells.  Well 1: HDPSC; Well 2: DynaMatrix membrane; 
and Well 3: HDPSC seeded on DynaMatrix membrane. 
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FIGURE 4. Test tube rack with test tubes containing the conditioned media 
collected from each of the three wells (HDPSC alone, DynaMatrix 
alone and HDPSC seeded on DynaMatrix membrane).  The 
experiment was run three times resulting in 9 separate samples.  
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FIGURE 5. Bovine Serum Albumin utilized in Bradford protein assay. 
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FIGURE 6.  Samples were placed in vials and then into the spectrophotometer.  
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FIGURE 7. UV/ Visible Spectrophotometer used for assessing protein 
concentrations.  
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FIGURE 8. RayBio® Human Angiogenesis Antibody Array 1 Kit.  Above: 
Closed box; Below: Open box. 
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FIGURE 9. Schematic illustration of the steps involved in cytokine array analysis. 
 
 
 
   
 
 
 
 
 
   
 
 
 
 
 
 
 
 
50 
 
           
 
   
FIGURE 10. Images of autoradiography films from the various samples.  From 
left to right:  Cell-only group (C); Membrane-only group (M); 
HDPSC seeded on DynaMatrix group (M+C).   
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TABLE I 
          
 
Key to abbreviations: 
Angiogenin: aka ribonuclease 5 
EGF: epithelial growth factor 
ENA-78: epithelial neutrophil-activating protein 78 
b FGF: basic fibroblast growth factor 
IFN-γ: interferon gamma 
IGF-1: insulin-like growth factor 1 
IL-6, 8: interleukin 6, 8 
MCP-1: monocyte chemotactic protein-1 
PDGF-BB: platelet-derived growth factor BB 
PIGF: Phosphatidylinositol-glycan biosynthesis class F 
protein 
TGF-β1: transforming growth factor beta 1 
TIMP-1, 2: tissue inhibitor of metalloproteinases 
metallopeptidase inhibitor 1, 2 
VEGF: vascular endothelial growth factor 
VEGF-D: vascular endothelial growth factor D 
POS: positive control 
Neg: negative control 
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TABLE II 
 Data summary of densitometry readings* 
Cytokine C M M+C 
Angiogenin 0.0075 (0.0026) 0.0068 (0.0040) -0.0040 (0.0062) 
EGF -0.0012 (0.0017) 0.0090 (0.0036) -0.0011 (0.0076) 
ENA-78 -0.0035 (0.0021) 0.0145 (0.0006) -0.0048 (0.0060) 
GRO 0.0141 (0.0118) -0.0014 (0.0035) 0.0067 (0.0078) 
IFN-gamma 0.0001 (0.0011) 0.0002 (0.0013) -0.0001 (0.0063) 
IGF-I -0.0022 (0.0026) 0.0014 (0.0021) -0.0002 (0.0062) 
IL-6 0.0239 (0.0050) 0.0034 (0.0008) 0.0015 (0.0034) 
IL-8 0.2541 (0.0478) 0.0351 (0.0096) 0.0042 (0.0031) 
Leptin -0.0065 (0.0014) 0.0047 (0.0020) -0.0038 (0.0035) 
MCP-1 0.5254 (0.0646) 0.0118 (0.0006) 0.0033 (0.0023) 
PDGF-BB -0.0067 (0.0009) 0.0075 (0.0010) 0.0020 (0.0030) 
PIGF -0.0049 (0.0024) -0.0023 (0.0031) -0.0052 (0.0060) 
RANTES 0.0126 (0.0101) 0.0032 (0.0004) 0.0101 (0.0041) 
TGF-beta 1 0.0067 (0.0044) 0.0025 (0.0018) 0.0015 (0.0060) 
TIMP-1 0.8444 (0.0402) 0.3995 (0.0054) 0.1707 (0.0777) 
TIMP-2 0.1267 (0.0242) 0.0017 (0.0082) -0.0059 (0.0002) 
Thrombopoietin -0.0065 (0.0022) -0.0011 (0.0001) -0.0031 (0.0015) 
VEGF -0.0044 (0.0010) -0.0002 (0.0002) -0.0054 (0.0001) 
VEGF-D -0.0046 (0.0023) 0.0055 (0.0020) 0.0022 (0.0000) 
bFGF -0.0032 (0.0005) 0.1309 (0.0232) 0.2052 (0.0282) 
  
  
* Mean densitometry values for each experimental group, followed by the 
standard error in parentheses. C: Cell-only group; M: DynaMatrix-only 
group;  M+C: HDPSC seeded on DynaMatrix. 
 
 
 
 
 
 
 
 
 
53 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
 
 
 
 
 
 
 
 
 
54 
 
 
 
 
One important finding from this study was that human dental pulp stem cells 
appeared to grow on DynaMatrix in vitro based on the measured differences in cytokine 
levels between the experimental groups.  This is one more characteristic of the membrane 
that makes it a possible candidate for future use as an intracanal scaffold for regenerative 
endodontic procedures.  
The results of this in vitro study supported the claim of the manufacturer that 
DynaMatrix contains “biological signals such as growth factors.”17  ENA-78, leptin, 
PDGF-BB, VEGF, VEGF-D and bFGF were all present in higher levels in the 
supernatant from the DynaMatrix-only group when compared to the HDPSC-only group.  
Since no cells were present in the DynaMatrix-only group to secrete these cytokines, the 
increased levels of these cytokines in the supernatant must have resulted from their 
having leached out of the membrane itself.  However, with the exception of bFGF, the 
levels of expression of the above-mentioned cytokines were so miniscule that while the 
differences were statistically significant, it is highly unlikely that biological or clinical 
significance can be ascribed to these differences.  As such, the discussion that follows 
will highlight only cytokines that were detected in quantities deemed sufficient to 
reasonably anticipate some biological effect.       
 In addition to increasing the levels of certain cytokines by simple diffusion from 
the DynaMatrix into the supernatant, the DynaMatrix appears to have had an effect on the 
expression of bFGF by the HDPSC.  The experimental group, which consisted of the 
HDPSC seeded on DynaMatrix, exhibited statistically significantly higher levels of bFGF 
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than the levels detected in the DynaMatrix-only and the HDPSC-only groups combined.  
This implies that the increased levels of bFGF in the experimental group were not due 
simply to additive effects between the cytokine molecules from the DynaMatrix and 
those from the HDPSC, but rather that DynaMatrix actually had some sort of stimulatory 
effects that resulted in greater bFGF expression from the HDPSC.    
 A different mechanism appears to have affected the levels of TIMP-1 and TIMP-2 
expression. These levels were highest in the HDPSC-only group, significantly lower in 
the DynaMatrix-only group and lowest in the experimental group (DynaMatrix + cells).  
While the expression of TIMP-1/-2 from the HDPSC was obviously reduced in the 
presence of DynaMatrix, one might expect that they would still be present in at least the 
same levels as that those seen in the DynaMatrix-only group since the membrane is 
present in both groups. However, the fact that the DynaMatrix + HDPSC group exhibited 
the lowest TIMP-1 and TIMP-2 levels suggests that the presence of the cells reduced the 
diffusion of TIMP-1 and TIMP-2 from DynaMatrix into the supernatant by some 
mechanism. Other possible mechanisms include some chemical interactions that result in 
tighter binding between TIMP and DynaMatrix, or actual uptake of TIMP by HDPSC 
that for some reason did not occur in the HDPSC-only group. 
The HDPSC-only group had significantly higher levels of IL-8, MCP-1, TIMP-1, 
and TIMP-2 than the other two groups.  Again, this would imply some interactions 
between the HDPSC and DynaMatrix that results in reduced expression of these 
particular cytokines by the HDPSC.  Otherwise, the HDPSC-only group and the 
experimental group (HDPSC + DynaMatrix) would have exhibited comparable levels.    
 It is interesting to note that in general, the interactions between the HDPSC and 
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DynaMatrix tended to result in an angiogenic cytokine profile that would seem to 
promote conditions conducive to achievement of some of the goals of regenerative 
endodontic procedures. For example, bFGF is present in DynaMatrix and DynaMatrix 
appears to promote expression of bFGF from HDPSC. FGF is secreted from a wide range 
of cells and promotes proliferation of a variety of cell-types. It can be applied in 
regenerative endodontic procedures to increase stem cell numbers.
86,113
 The interaction of 
HDPSC and DynaMatrix also resulted in significantly lower levels of TIMP-1 and TIMP-
2. There are four isotypes of TIMP119, and types 1-3 have been shown to have an 
inhibitory effect on angiogenesis.
119-121
  IL-8 levels were found to be significantly lower 
when HDPSC were seeded on DynaMatrix compared to HDPSC alone.  IL-8 has been 
shown to play a role in angiogenesis, sometimes promoting and sometimes inhibiting 
angiogenesis depending upon the interplay between multiple chemical messengers in the 
local microenvironment.
113-115
  However, IL-8 is also affiliated with inflammatory 
processes and has been shown to even play a “causative role in acute inflammation by 
recruiting and activating neutrophils.”154 A state of inflammation is generally considered 
detrimental to the success of regenerative endodontic procedures, especially in the case of 
teeth that have undergone trauma. In these teeth, damage to the predentin and 
precementum layers can lead to root resorption in the presence of inflammation.
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 The decreased MCP-1 levels seem to present an exception to the general trend 
observed in this study that the experimental group (HDPSC + DynaMatrix) exhibited a 
cytokine profile conducive to the goals of endodontic regenerative procedures. MCP-1 
has been shown to promote angiogenesis in multiple studies,
111,156-158
  though the exact 
mechanism by which it achieves this is not completely understood.
159
  However, like IL-
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8, MCP-1 has been shown to be an important mediator of inflammation,
160
 which may 
pose an obstacle to regeneration.        
 The preceding discussion highlights generalities concerning the roles of specific 
cytokines, but it is important to recognize that the effect of individual cytokines is 
complicated by various factors. In vivo, cytokines may have different effects depending 
upon their target cell types. Their effects can also be dose-dependent.  Therefore, the 
findings of an in-vitro study such as this may not be directly applicable to an in-vivo 
situation.  In addition, many of the studies involving research into the roles of various 
cytokines in the process of angiogenesis use animal models and focus on tumor 
angiogenesis in various parts of the body other than the jaws. The findings of these 
studies may involve important differences from the specific clinical situation involved in 
regenerative endodontic procedures.        
 One issue that affects the feasibility of regenerative endodontic procedures is the 
resorbability of the scaffold.  The rate at which the scaffold resorbs should mimic as 
closely as possible the rate of tissue formation.
86
  Collagen has been suggested as a 
possible intracanal scaffold for regenerative endodontic procedures.
85
  A recent study 
involving revascularization of rat teeth found that an injectable Type 1 collagen scaffold 
was replaced after eight weeks by vascularized connective tissue, thereby “confirming its 
biodegradability and potential use as a scaffold for pulp cell engineering.”11  One study to 
investigate techniques for treatment of bone defects in a rat model utilized SIS 
membranes.  The bone defects in the rat femurs were treated with bone allograft seeded 
with mesenchymal stem cells (MSC) and growth factors.  This was then wrapped with 
SIS that had been seeded with mesenchymal stem cells.  The analysis of the SIS 
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membrane demonstrated its complete resorption by 9 weeks.
161
  As DynaMatrix is an SIS 
membrane that contains collagen, it would likely exhibit a similar rate of resorption (8-10 
weeks) as that found in the two aforementioned studies which would be appropriate for 
regenerative endodontic procedures.
11
        
 As discussed above, another critical issue influencing the outcomes of 
regenerative endodontic procedures is the elimination of microbes from the root canal 
space (RCS).  To this end, most suggested protocols recommend copious irrigation 
followed by placement of an intracanal medicament to maximize microbial elimination.  
Nevertheless, recent research indicates that even the most meticulous efforts to eradicate 
microbes from the RCS are never 100-percent successful.
162,163
  In light of this reality, 
various authors have encouraged the development of a scaffold that contains an 
antimicrobial component for use in regenerative endodontic procedures.
85,86,90
  
DynaMatrix has no documented antibiotic effects, so addition of an antibiotic to the 
membrane or simultaneous use of the membrane with an intracanal antibiotic solution or 
paste would likely increase its appeal for use in regenerative endodontics.   
 Future research could include a similar study design to the one utilized in this 
investigation, but could substitute different dental stem cells types such as periodontal 
ligament stem cells (PDLSC), stem cells of the apical papilla (SCAP) or stem cells from 
human exfoliated deciduous teeth (SHED).  Further clinical relevance could be achieved 
by studying the interaction between DynaMatrix and a mixed population of various cell 
types, rather than a single cell type. The expression of different cytokines could also be 
studied readily as the manufacturer offers custom-made cytokine array membranes that 
can be designed to screen for specific cytokines as requested by the researcher.
164
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Eventual animal studies could follow, and human in-vivo studies could be expedited by 
the fact that DynaMatrix already has a long track record of safe clinical use in humans. 
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 The null hypothesis was rejected because statistically significant differences in the 
expression of angiogenic cytokines were demonstrated between the experimental group 
(HDPSC seeded on DynaMatrix) when compared with the control groups (HDPSC-only 
or DynaMatrix-only). Specifically, bFGF was significantly highest in the DynaMatrix + 
HDPSC group, lower in the DynaMatrix-only group, and lowest in the HDPSC-only 
group.  In addition, IL-8, MCP-1, TIMP-1 and TIMP-2 were highest in the HDPSC-only 
group, lower in the DynaMatrix-only group, and lowest in the HDPSC + DynaMatrix 
group.  Statistically significant differences in the levels of other cytokines were detected 
between the groups, but those particular cytokines were present in such small quantities 
that they were deemed unlikely to result in any biological effects.  
 DynaMatrix could potentially improve the regenerative endodontic procedure by 
providing a predictable mechanical scaffold for cellular and vascular in-growth into the 
root canal system. Additionally, it may improve angiogenesis by increasing the quantity 
of angiogenic cytokines present in the microenvironment via release of cytokines present 
in DynaMatrix, as well as possible interactions with the cells involved in regeneration 
that result in greater expression of angiogenic cytokines from these cells. Lastly, it may 
aid endodontic regenerative procedures by down-regulating the expression of potential 
inhibitors of angiogenesis such as IL-8, MCP-1 and TIMP-1 and TIMP-2.    
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EFFECTS OF DYNAMATRIX® MEMBRANE ON ANGIOGENIC CYTOKINE 
EXPRESSION FROM HUMAN DENTAL PULP STEM CELLS 
 
 
 
by 
Ryan William Baker 
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Historically, treatment protocols for infected, immature teeth involved 
disinfection of the root canal space (RCS) followed by creation of an apical barrier and 
subsequent obturation. While generally effective at removing the source of infection, 
these methods result in teeth with thin, underdeveloped roots that were prone to fracture 
over time. 
An alternative to the conventional methods is now available in the form of 
regenerative endodontic procedures. These are currently performed to treat infected 
immature teeth with the “revascularization method.”7  This method includes two steps: 
disinfection of the root canal, and then laceration of apical tissues to induce blood flow 
into the root canal space. The blood clot formed in the canal serves as a fibrin scaffold for 
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the accumulation of stem cells and other cells with dentin/root formation capability. This 
protocol has resulted in continued root formation (in length and width) in certain clinical 
cases.  However, the adequacy of the hemorrhage induced in the apical tissues has a 
significant impact on the quality of the regenerated dental structures. This phenomenon 
indicates that the blood clot itself may play an important role in continued root formation 
by locally releasing molecular signals, which induce angiogenesis. Successful 
angiogenesis is then crucial for the vitality of the newly regenerated pulp tissues and for 
the initiation of continued root development. Therefore, either the production of 
angiogenic cytokines from the local surviving cells, or the effective delivery of 
exogenous angiogenic cytokines to the desired area is one of the key components in 
regenerative endodontic treatment.          
 It is believed that an appropriate exogenous scaffold could aid the endogenous 
elements (fibrin meshwork and molecular signals in the blood clot) and result in more 
predictable regenerative endodontic procedures. DynaMatrix® is a biological 
extracellular matrix (ECM) scaffold product that is marketed to dental practitioners. In 
addition to structural and functional proteins (collagens types I, III, IV, and VI, 
glycosaminoglycans, glycoproteins, proteoglycans), DynaMatrix contains biological 
signals such as cytokines. Its track record of successful use in periodontal procedures 
encourages investigation of the material for use in regenerative endodontic procedures.  
Specifically, DynaMatrix may be placed within the root canal system of the immature 
tooth to facilitate the continued development of the entire length of the root from the 
apical foramen to the level of the dentin enamel junction (DEJ). As a scaffold containing 
biological signals, DynaMatrix has the potential to induce angiogenesis and encourage 
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the migration of cells that are involved in the continued development of the root canal 
system. 
The aim of this current study was to determine if the exposure of human dental 
pulp stem cells (HDPSC) to the DynaMatrix membrane will result in an increased 
production of angiogenic growth factors that are critical for pulp/root regeneration. This 
study used HDPSC in vitro. Three different groups were tested as follows: 1) control 
group #1, Human Dental Pulp Stem Cell (HDPSC) culture only; 2) control group #2, 
DynaMatrix 
 
membranes placed in culture media without any cells present, and 3) the 
experimental group, HDPSC seeded on DynaMatrix® membranes. The conditioned 
media from the various groups were collected and tested for the expression of specific 
cytokines using angiogenesis cytokine arrays, which have been established as a viable 
method for assessing expression of angiogenic cytokines. 
To determine the level of cytokine expression, the optical densities of the visible 
dots on the membrane were measured by Quantity One 1-D Analysis Software (Bio-
Rad). For each membrane, the density of each dot was adjusted for the background by 
subtracting the average value of the negative controls on each membrane and then 
normalized by dividing by the average of the positive controls. The experiment was run 
three times resulting in three membranes for each group. This generated four to six 
densitometry readings (two per membrane, some statistical outliers removed) for each 
cytokine in each group. Group comparisons were performed using one-way ANOVA. 
The cell-only group (C) had significantly lower ENA-78 (p = 0.0166); leptin (p = 
0.0208); PDGF-BB (p = 0.0034); VEGF (p = 0.0174); VEGF-D (p = 0.0230), and bFGF 
(p = 0.0047) compared with the DynaMatrix membrane-only group (M). C had 
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significantly higher IL-6 (p = 0.0268); IL-8 (p = 0.0153); MCP-1 (p = 0.0021); TIMP-1 
(p = 0.0027), and TIMP-2 (p = 0.0105) compared with M. 
C had significantly lower PDGF-BB (p = 0.0182) and bFGF (p = 0.0009) 
compared with the DynaMatrix membrane + dental pulp stem cell group (M+C). Control 
had significantly higher IL-6 (p = 0.0203); IL-8 (p = 0.0097); MCP-1 (p = 0.0019); 
TIMP-1 (p = 0.0006); and TIMP-2 (p = 0.0086) compared with M+C.  C and M+C did 
not have significantly different ENA-78 (p = 0.78); leptin (p = 0.42); VEGF (p = 0.42), or 
VEGF-D (p = 0.07). 
M had significantly lower bFGF (p = 0.0452) compared with M+C. M had 
significantly higher ENA-78 (p = 0.0178); TIMP-1 (p = 0.0363); and VEGF (p = 0.0117) 
compared with M+C. M and M+C did not have significantly different IL-6 (p = 0.79); IL-
8 (p = 0.63); leptin (p = 0.06); MCP-1 (p = 0.92); PDGF-BB (p = 0.10); TIMP-2 (p = 
0.81), or VEGF-D (p = 0.34).         
 The results of this study indicate that that DynaMatrix may contribute to success 
in regenerative endodontic procedures by providing a predictable mechanical scaffold for 
cellular and vascular in-growth into the RCS. Additionally, it may improve angiogenesis 
by increasing the quantity of angiogenic growth factors present in the microenvironment 
via release of angiogenic cytokines present in DynaMatrix, as well as through possible 
interactions with the cells involved in regeneration that result in greater expression of 
angiogenic cytokines from these cells.     
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